Trade Summary

3 months ago, Altman Peter, serving as Pres, CEO at Biocardia, Inc. (BCDA), purchased 48,000 shares at $1.25 per share, for a total transaction value of $60,000.00. Following this transaction, Altman Peter now holds 216,762 shares of BCDA.

This purchase represents a 28.00% increase in Altman Peter's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, September 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 23, 2025, 4 days after the trade was made.

Biocardia, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.